AstraZeneca and Oracle plan to combine drug development expertise with artificial intelligence and healthcare data to identify eligible patients for clinical trials and monitor safety signals

Overview Debates Related claims Topics Sources

Machine-learning antibody profiles differentiated individuals who later developed complicated Crohn's disease from non-complicated Crohn's disease up to approximately 10 years before diagnosis with an AUC value of 0.85.

Machine-learning models integrating early antibody signatures discriminated individuals who would later develop Crohn's disease or ulcerative colitis from healthy controls up to 10 years before diagnosis, with AUC values of 0.90 and 0.84, respectively.

The Percival artificial intelligence model operates in the background to identify health patterns, clinical outcomes, and connections between CT scans, lab values, and physiology without requiring specific direction to search for particular outcomes.

On October 20, 2026, AstraZeneca announced a collaboration with Oracle to leverage artificial intelligence, cloud, and healthcare data capabilities to refine clinical research

The World Health Organization Regional Office for Africa used artificial intelligence analysis in the Democratic Republic of Congo to reduce situation report generation time from a full working day to one hour.

Response teams in the Democratic Republic of Congo fighting the Bundibugyo strain of Ebola virus used Anthropic's Claude model to evaluate digitized health worker field reports.

Moody's warned in August 2026 that technology providers OpenAI and Anthropic face investor pressure to reach profitability, creating potential pricing leverage over dependent financial institutions.

Proscia's software converts physical pathology slides into digital images that can be stored, reviewed, and analyzed using artificial intelligence tools.

The acquisition of Proscia establishes an Agilent platform for scientific intelligence in tissue-based precision medicine, connecting data generation with AI-based interpretation.

The acquisition of Proscia is intended to offer AI-enabled synergies with Agilent Technologies' companion diagnostics business in drug discovery and clinical research.

The Upper Merion expansion forms part of a broader $1.2 billion investment by GSK earmarked for advanced manufacturing, artificial intelligence, and digital technologies.

Building AI-native hospitals from scratch is more effective than retrofitting legacy health systems

The University of Texas at Austin is designing an academic medical center built around artificial intelligence prior to beginning construction.

Dell Medical School dean Dr. Claudia Lucchinetti described the tentacle problem as tacking new artificial intelligence tools and workflows onto broken legacy IT systems built decades earlier.

At a MAHA event on September 28, 2026, Robert F. Kennedy Jr. outlined a vision to connect and share U.S. medical and lifestyle data with the government and independent researchers to be analyzed by artificial intelligence.

Codametrix and Solventum stated they have integrated strict coding compliance guidelines and guardrails into their artificial intelligence systems to prevent inaccurate or fraudulent coding.

PwC analysts attribute a projected 9% increase in health insurers' medical costs for 2027 to the adoption of artificial intelligence-backed billing tools.

Health insurers, including Centene, stated that the use of artificial intelligence tools by health systems has led to aggressive or inappropriate reimbursement payments.

Abridge founder Dr. Shiv Rao stated that while artificial intelligence could lead to a dystopian scenario of automated systems fighting, it might also reduce billing tensions and cut costs.

Solventum deputy chief medical officer Dr. Travis Bias stated that transitioning to value-based care models, which reimburse based on patient outcomes rather than volume, could resolve artificial intelligence-driven billing cost challenges.